To protect our staff and visitors from COVID-19, OPA office staff will work remotely. We’ll continue to be fully operational to serve our members. Contact us at 416-441-0788 or 1-877-341-0788 or mail@opatoday.com.

Publications

  • Annual Report 2018-19

    A look at the activities of the Ontario Pharmacists Association over the past Board year (June 2018 – June 2019).

  • The Ontario Pharmacist – Volume 83 / Issue 1 / 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Q&A with André Picard – Canada's Health Hero

  • OPA Bulletin - June 11, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • ICYMI: PxP2019 update on scope expansion
    • Pharmacy practice research winners at PxP2019
    • Opioid overdose: age is no safety net
    • Updated antiemetic recommendations
    • A limited quantity of U.S.-labeled potassium chloride for injection USP concentrate (2mEq/mL) in the 20mL format will be made available for Canadian patients
    • Fludarabine supply status and conservation strategies

    • Medical Devices Training For Pharmacy Technicians
    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • Board Certified Geriatric Pharmacist (BCGP) Preparation Course – Medication Therapy Management for Older Adults

    • Ask the Practice Support Network

    • Do I really need life insurance?

    • DDD Notice No. 19086 posted June 05, 2019 Prescription Forgery Alert
    • DDD Notice No. 19087 posted June 06, 2019 Prescription Forgery Alert
    • DDD Notice No. 19090 posted June 10, 2019 Health Network System (HNS) and Narcotic Monitoring System (NMS) outages notification to ODP agencies

    • Health products manufactured by Konsar Future Nutrition Inc. may pose serious health risks

  • OPA Bulletin - June 4, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA announces award winners at PxP2019
    • Here's what you're missing at PxP2019!
    • Pikangikum evacuation plan

    • Women’s Health Conditions
    • Managing Your Pharmacy: The Business Essentials
    • Pharmacist Health Coaching - Cardiovascular Program Training Course

    • Ask the Customer Experience and Administration Team

    • Your questions answered on disability insurance

    • DDD Notice No. 19082 posted May 31, 2019 Prescription Forgery Alert
    • DDD Notice No. 19083 posted May 31, 2019 Identified Forgery Alert – 120 Oxycocet Pills
    • DDD Notice No. 19084 posted May 31, 2019 ODB gFOBT PIN to be Discontinued
    • DDD Notice No. 19085 posted June 04, 2019 Notice from the Executive Officer: Change to the Health Network System Subscription Agreement for Pharmacy Operators

    • Health Product InfoWatch - Safety Updates: Eliquis, Fentora and Keytruda
    • Alaris Infusion Sets and Alaris 8100 Pump Module - Health Product Risk Communication - Update – Thursday, May 30th, 2019
    • IMPORTANT: Drug Shortage Notification – Multiple Sterile Injectable Products
    • Biocell breast implants - Information Update

  • OPA Bulletin - May 28, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • OPA and Neighbourhood Pharmacies oppose government's proposal to extract $140 million annually from pharmacy
    • Last chance to register for conference - registration closes Thursday!
    • Discontinuation Notice - PrDepo-Provera® (medroxyprogesterone acetate, USP) 50 mg/mL in 1 x 5 mL Vial
    • Drug Supply Health System Alert: OncoTICE
    • IMPORTANT: Notification Regarding PrNORVASC® (amlodipine besylate) 10 mg tablets in bottles of 250.
    • Re-issuing Spring Issue of Ontario Pharmacist

    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • How-To: Ontario’s Pharmaceutical Opinion Program
    • Asthma Management: The Essentials

    • Summer's almost here! Time to get your Canada's Wonderland passes
    • Ask the Practice Support Network

    • Are you considering Joining a Local Area Network (LAN) or Wide Area Network (WAN)?

    • DDD Notice No. 19081 posted May 23, 2019 ODB FORMULARY – EDITION NO. 43, Summary of Changes – May 2019

  • Spring 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    Focus On: Opioid Switching in the Chronic Pain Patient - Part 1

  • OPA Bulletin - May 21, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Applications for the Universal Influenza Immunization Program (UIIP) are being accepted by the Ministry for 2019/20 influenza season
    • Be heard! Last chance to submit comments to Ministry on proposed amendments
    • Don't miss these PxP2019 conference sessions on scope of practice, drug shortages and cannabis
    • Sports journalist and mental health advocate, Michael Landsberg to open PxP2019 trade show

    • Injections and Immunizations Certificate Program - Blended
    • Injections and Immunizations Refresher - Blended
    • Delivering a Comprehensive Pharmacy-Based Vaccines Program

    • Check out our new membership benefit with Manulife Bank!*
    • Ask the Customer Experience and Administration Team

    • Time to renew your store insurance

    • DDD Notice No. 19078 posted May 17, 2019 Prescription Forgery Alert
    • DDD Notice No. 19080 posted May 21, 2019 Prescription Forgery Alert

    • Important Safety Information on ACTEMRA® (tocilizumab) - Risk of Hepatotoxicity - Hoffmann-La Roche Limited

  • OPA Bulletin - May 14, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Deadline to provide feedback to government on amendments to regulations is May 24, 2019
    • OPA and Neighbourhood Pharmacies request your input to long-term care survey
    • OPA participates in conversation in long-term care at AdvantAge Convention
    • Spring 2019 Issue of Ontario Pharmacist featuring Q&A with conference keynote, André Picard, now available
    • Registered yet for conference? Deadline is approaching!

    • Medical Devices Training for Pharmacy Technicians
    • Personal Branding for Pharmacy Professionals
    • Dermatologic Conditions

    • Sneak preview to new membership benefit with Manulife Bank!
    • Ask the Practice Support Network

    • “Must Have Insurance”

    • DDD Notice No. 19075 posted May 10, 2019 Prescription Forgery Alert
    • DDD Notice No. 19072 posted May 09, 2019 Prescription Forgery Alert

  • OPA Bulletin - May 7, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Provide Your Feedback to Health Quality Ontario - A Quality Standard for Transitions from Hospital to Home
    • Drug Shortage Notification – Potassium Chloride for Injection Concentrate USP (2 mEq (mmol) / mL) and Epinephrine Injection USP 0.1 mg / mL (LifeShield Syringes)

    • Asthma Management: The Essentials
    • Billing 101: Ontario Drug Benefit (ODB) and Third-Party Insurance
    • Delivering a Comprehensive Pharmacy-Based Vaccines Program

    • Special Conference Promotion - Save $100
    • Last Week for Hotel Reservations for PxP2019
    • Ask the Customer Experience and Administration Team

    • Is your store properly insured?

    • DDD Notice No. 19070 posted May 02, 2019 HEALTH NETWORK SYSTEM (HNS) AND NARCOTICS MONITORING SYSTEM (NMS) OUTAGE NOTIFICATION TO ODP AGENCIES
    • DDD Notice No. 19071 posted May 02, 2019 Prescription Forgery Alert

    • Paclitaxel-Coated Balloons (PCB) and Paclitaxel-Eluting Stents (PES) for the Treatment of Peripheral Arterial Disease (PAD) and the Potential Risk of Long-Term All-Cause Mortality

  • OPA Bulletin - April 30, 2019

    This content is only available to Association members. Please log in to access this content.

    Become a member

    or Sign In

    • Your questions answered on recent proposed pharmacy regulations from Ontario government
    • Canadian Foundation for Pharmacy happenings
    • Pharmacies surpass doctors’ offices as primary venue for influenza vaccination
    • OPA represents at Momentum Loblaw/SDM trade show

    • An Update on Direct Oral Anticoagulation
    • Essential Cannabis Knowledge for Pharmacists - Certificate Program
    • Patient Assessment and Triage

    • First 100 will save $100 on conference registration
    • Ask the Practice Support Network
    • Spring time discounts with Royal Ontario Museum
    • Reminder to members in voting districts

    • Life Insurance v.s. Mortgage Insurance

    • DDD Notice No. 19066 posted April 25, 2019 Notice: Proposals to Establish More Efficient Pharmacy Reimbursement Policies
    • DDD Notice No. 19067 posted April 26, 2019 Notice from the Executive Officer
    • DDD Notice No. 19068 posted April 30, 2019 Prescription Forgery Alert
    • DDD Notice No. 19069 posted April 30, 2019 Prescription Forgery Alert

    • Health Canada advises Allergan of its intent to suspend its licences for Biocell breast implants as a precautionary measure
    • Health Product InfoWatch
    • Alaris Infusion Sets and Alaris 8100 Pump Module - Risk of Over-Infusion

Back to top